— Know what they know.
Not Investment Advice

000710.SZ SHZ

Berry Genomics Co.,Ltd
1W: +14.2% 1M: +21.9% 3M: +38.5% YTD: -14.4% 1Y: -26.5% 3Y: -1.8% 5Y: -64.1%
¥10.87 ($1.62)
+0.99 (+10.02%)
 
SHZ · Healthcare · Medical - Diagnostics & Research · Tech Score Buy · Power 64 · ¥3.8B mcap · 314M float · 5.60% daily turnover
Smart Money Score
Watch 25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap¥3.8B ($573.0M)
52W Range7.2-15.63
Volume25,344,769
Avg Volume17,548,045
Beta0.48
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOYang Gao
Employees1,331
SectorHealthcare
IndustryMedical - Diagnostics & Research
IPO Date1997-04-22
Building 5
Beijing, BE 102206
CN
86 10 5325 9188
About Berry Genomics Co.,Ltd

Berry Genomics Co.,Ltd, a genomics and life science company, develops and commercializes of genetic test technologies in clinical applications in China. The company offers non-invasive DNA prenatal testing service, genetic disease testing, tumor genetic testing, NextSeq CN500 gene sequencer, and laboratory solutions. It also provides technology services, such as human genome sequencing, transcriptional regulation, single cell/spatial sequencing, animal and plant genome resequencing, genome denovo sequencing, and microbial sequencing, as well as big data services. The company serves various organizations and facilities, including hospitals, research institutions, universities, and enterprises throughout Mainland China, Hong Kong, Macao, Taiwan, Southeast Asia, the Middle East, and Australia. The company was founded in 2010 and is headquartered in Beijing, China.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms